Literature DB >> 9693392

Serotonin and neuropeptides in affiliative behaviors.

T R Insel1, J T Winslow.   

Abstract

The neuropharmacological study of serotonin and behavior has followed two fundamentally different strategies. One approach has used behavior as a dependent variable for assaying drug effects. To characterize serotonergic drugs, most studies have used relatively simple behaviors, such as locomotor activity, startle, exploration, operant responses, and sleep. A second approach has focused on behavior, with drugs used as tools to elucidate the physiological role of serotonin. These studies have increasingly focused on behaviors of ethological importance, including aggression, sexual behavior, and other forms of social interaction. Here we review studies using this approach to focus on one particular kind of social interaction: affiliation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693392     DOI: 10.1016/s0006-3223(98)00094-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  20 in total

1.  Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality.

Authors:  Yves Aubert; Morgan L Gustison; Lindsey A Gardner; Michael A Bohl; Jason R Lange; Kelly A Allers; Bernd Sommer; Nicole A Datson; David H Abbott
Journal:  J Sex Med       Date:  2012-02-03       Impact factor: 3.802

2.  The enduring effects of abuse and related adverse experiences in childhood. A convergence of evidence from neurobiology and epidemiology.

Authors:  Robert F Anda; Vincent J Felitti; J Douglas Bremner; John D Walker; Charles Whitfield; Bruce D Perry; Shanta R Dube; Wayne H Giles
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-11-29       Impact factor: 5.270

3.  Oxytocin improves specific recognition of positive facial expressions.

Authors:  Abigail A Marsh; Henry H Yu; Daniel S Pine; R J R Blair
Journal:  Psychopharmacology (Berl)       Date:  2010-02-26       Impact factor: 4.530

4.  Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL/6J mice.

Authors:  Sheryl S Moy; Randal J Nonneman; Geoffrey O Shafer; Viktoriya D Nikolova; Natallia V Riddick; Kara L Agster; Lorinda K Baker; Darin J Knapp
Journal:  Neurotoxicol Teratol       Date:  2012-08-07       Impact factor: 3.763

5.  Role of vasopressin V1a receptor in ∆9-tetrahydrocannabinol-induced cataleptic immobilization in mice.

Authors:  Nobuaki Egashira; Emi Koushi; Takayuki Myose; Akito Tanoue; Kenichi Mishima; Ryota Tsuchihashi; Junei Kinjo; Hiroyuki Tanaka; Satoshi Morimoto; Katsunori Iwasaki
Journal:  Psychopharmacology (Berl)       Date:  2017-09-14       Impact factor: 4.530

6.  A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior.

Authors:  Kevin Chen; Daniel P Holschneider; Weihua Wu; Igor Rebrin; Jean C Shih
Journal:  J Biol Chem       Date:  2004-07-22       Impact factor: 5.157

7.  Altered social behavior in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice.

Authors:  Arnaud Nicot; Timothy Otto; Philippe Brabet; Emanuel M Dicicco-Bloom
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

8.  Genetic contributions of the serotonin transporter to social learning of fear and economic decision making.

Authors:  Liviu G Crişan; Simona Pana; Romana Vulturar; Renata M Heilman; Raluca Szekely; Bogdan Druğa; Nicolae Dragoş; Andrei C Miu
Journal:  Soc Cogn Affect Neurosci       Date:  2009-06-17       Impact factor: 3.436

Review 9.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

10.  Asic3(-/-) female mice with hearing deficit affects social development of pups.

Authors:  Wei-Li Wu; Chih-Hung Wang; Eagle Yi-Kung Huang; Chih-Cheng Chen
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.